Siga Technologies Reports Major Revenue Drop in Q1 2025 Amid Sales Contract Fluctuations

Siga Technologies Inc. (NASDAQ: SIGA) has released its financial results for the three months ended March 31, 2025. The report reveals significant changes in revenues due to fluctuations in sales contracts, particularly related to the U.S. Government.

Income Statement Highlights:

• Total Revenues: $7.04 million, down from $25.43 million in Q1 2024.
• Product Sales: $5.82 million, compared to $23.88 million in the same period last year.
• Research and Development Revenue: $1.22 million, lower than the previous $1.55 million.
• Operating Expenses: Totaled $9.30 million, down from $14.15 million a year ago.
• Operating Loss: $2.26 million compared to an operating income of $11.28 million in Q1 2024.
• Net Loss: $408,223 compared to net income of $10.28 million in the prior year.
• Earnings Per Share: Basic and diluted loss per share of $0.01, down from earnings of $0.14.

Positive Aspects:

• Improved efficiency reflected in lower operating expenses, which decreased from $14.15 million to $9.30 million.
• Cash and cash equivalents increased to $162.27 million, up from $155.40 million at year-end 2024.
• Continued backing from BARDA with the potential for contract modifications playing a critical role in future revenues.

Negative Aspects:

• Substantial drop in total revenues driven primarily by lower product sales, particularly oral TPOXX®.
• Operating loss and net loss figures indicate a challenging quarter for the company, particularly compared to an exceptionally strong Q1 2024.
• A significant decline in income before income taxes, falling from $13.22 million to a loss of $570,415.

Other Key Statistics:

• Accounts Receivable: $7.19 million, down from $21.17 million.
• Inventory: Increased to $59.06 million from $49.56 million.
• Accrued Expenses: Spike to $16.23 million from $5.64 million the previous quarter.
• Effective Tax Rate: For Q1 2025 at 28.4% compared to 22.2% in Q1 2024.

Siga Technologies continues to navigate a complex business environment, balancing challenges in sales while improving operational efficiency. Its future hinges on the execution of government contracts and potential new applications for its TPOXX® product line.